Risk factor of non-tuberculous Mycobacteriuminfection in patients with rheumatoid arthritis and other autoimmune diseases receiving biologic agents: A multicenter retrospective study

Autor: Ashizawa, Hiroki, Takazono, Takahiro, Kawashiri, Shin-ya, Nakada, Nana, Ito, Yuya, Ashizawa, Nobuyuki, Hirayama, Tatsuro, Yoshida, Masataka, Takeda, Kazuaki, Iwanaga, Naoki, Takemoto, Shinnosuke, Ide, Shotaro, Mihara, Tomo, Tomari, Shinya, Sakamoto, Noriho, Obase, Yasushi, Izumikawa, Koichi, Yanagihara, Katsunori, Kawakami, Atsushi, Mukae, Hiroshi
Zdroj: Respiratory Investigation; 20240101, Issue: Preprints
Abstrakt: Evidence regarding the association of the usage of biologic agents (Etanercept, Tocilizumab, adalimumab and so on), such as anti-tumor necrosis factor α, with the incidence and risk factors of non-tuberculous Mycobacteria(NTM) infection is limited. Therefore, this study aimed to investigate the incidence and risk factors of NTM and their associations with biologic agents’ usage, and also investigated the potential of Mycobacterium aviumcomplex (MAC) antibodies as a predictor of NTM infection development.
Databáze: Supplemental Index